Difference between revisions of "Pilot Conformance Projects Under Development"
Jump to navigation
Jump to search
m |
m |
||
| Line 15: | Line 15: | ||
Before starting conformance testing, please [mailto:qiba@rsna.org Email QIBA] | Before starting conformance testing, please [mailto:qiba@rsna.org Email QIBA] | ||
| − | QIBA Profiles that are available for self-attestation conformance testing: | + | == <font color=green>'''QIBA Profiles that are available for self-attestation conformance testing:'''</font> == |
==CT: Lung Tumor Volume (Advanced Disease)== | ==CT: Lung Tumor Volume (Advanced Disease)== | ||
Revision as of 18:21, 13 November 2019
QIBA Profile Conformance
{This content will eventually be available on the RSNA.org website.}
QIBA Profiles that are at least at consensus level (link to wiki page on development of a Profile) are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile. There are two different ways to show QIBA Profile conformance:
- Self – attestation
- Certification service
The basic process flow is shown below:
Before starting conformance testing, please Email QIBA
QIBA Profiles that are available for self-attestation conformance testing:
CT: Lung Tumor Volume (Advanced Disease)
- Profile
- CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22
- Checklist
- CT Conformance Checklist (can also refer to Appendix C in the Profile document - pg 42)
- Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
- Report Template
FDG-PET: Solid Tumor SUV
- Profile
- FDG-PET/CT for Response to Cancer Therapy 2016-11-18
- Checklist
- QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11
- Report Template
MR: ADC-DW MR Lesions in Four Organs
- Profile
- Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05
- Checklist
- QIBA DWI-MRI Conformance Checklist, 2019-11-11
- Report Template